Ho‐Jin Shin

Daratumumab plus bortezomib and dexamethasone <i>versus</i> bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR

Andrew Spencer, Suzanne Lentzsch, Katja Weisel et al. · Haematologica · 2018 · 262 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Dae‐Young Kim, Young‐Don Joo, Sung-Nam Lim et al. · Blood · 2015 · 184 citations · Full text

Medicine, Oncology, Pharmacology +11

Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells

Ho‐Jin Shin, Jeanette Baker, Dennis B. Leveson-Gower et al. · Blood · 2011 · 149 citations

Life Sciences, Cell Biology, Immunology +14

Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement

Joo-Seop Chung, Ho‐Jin Shin, Sang‐Min Lee et al. · Annals of Hematology · 2011 · 140 citations · Full text

Medicine, Oncology, Hematologic Oncology +16

Safety and efficacy of BAY 94‐9027, a prolonged‐half‐life factor VIII

Mark T. Reding, Hannah Jia Hui Ng, Lone Hvitfeldt Poulsen et al. · Journal of Thrombosis and Haemostasis · 2016 · 116 citations · Full text

Medicine, Hematology, Pharmacotherapy +17